Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancerTomohiro Kaku, Akihiro Tasaka, Takahito Hara et al.|Bioorganic & Medicinal Chemistry|2011Cited by 126
Suppression of a Pituitary-Ovarian Axis by Chronic Oral Administration of a Novel Nonpeptide Gonadotropin-Releasing Hormone Antagonist, TAK-013, in Cynomolgus MonkeysTakahito Hara, Masahiko Fujino, Hideo Araki et al.|The Journal of Clinical Endocrinology & Metabolism|2003Cited by 31
In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture TherapyAtsushi Fujimura, Shuichi Furuya|Cells|2020Cited by 30
Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonistsSatoshi Yamamoto, Mitsuhiro Ito, Kazumasa Hamamura et al.|Bioorganic & Medicinal Chemistry|2011Cited by 19